Rationale and Design for the Study of Rivaroxaban to Reduce Thrombotic Events, Hospitalization and Death in Outpatients with COVID-19: the PREVENT-HD Study

Publication date: Available online 9 February 2021Source: American Heart JournalAuthor(s): Warren H. Capell, Elliot S. Barnathan, Gregory Piazza, Alex C. Spyropoulos, Judith Hsia, Scott Bull, Concetta Lipardi, Chiara Sugarmann, Eunyoung Suh, Jaya Prakash Rao, William R. Hiatt, Marc P. Bonaca

Source: American Heart Journal - February 10, 2021 Category: Cardiology Source Type: research